New Jersey S 3423: Codifies certain regulatory provisions regarding controlled dangerous substances and prescription monitoring.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2019-02-07)

State: New Jersey · Session: 218 · Bill: S 3423

Subjects: DRUG ABUSE, PHARMACEUTIC

Sponsors: Singer, Robert W.

View New Jersey S 3423 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.